U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07950592) titled 'The ABODE Study for Patients Undergoing Neoadjuvant Chemotherapy' on Oct. 28.

Brief Summary: Over 12,000 women in Ontario will be diagnosed with BC this year. The COVID-19 pandemic changed the healthcare system, making it important to have high-quality virtual (online) care. Mobile health, which means getting health services on your phone, has become a common part of healthcare.

A previously developed app will be used in this study to improve the virtual care experience for BC patients that will be undergoing neoadjuvant chemotherapy. With this app, patients can:

* Get personalized resources that can help them navigate through the...